1. Home
  2. NFE vs ARMP Comparison

NFE vs ARMP Comparison

Compare NFE & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo New Fortress Energy Inc.

NFE

New Fortress Energy Inc.

HOLD

Current Price

$0.69

Market Cap

324.4M

Sector

Utilities

ML Signal

HOLD

Logo Armata Pharmaceuticals Inc.

ARMP

Armata Pharmaceuticals Inc.

N/A

Current Price

$8.06

Market Cap

295.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NFE
ARMP
Founded
2014
N/A
Country
United States
United States
Employees
N/A
61
Industry
Oil/Gas Transmission
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
324.4M
295.5M
IPO Year
2018
1996

Fundamental Metrics

Financial Performance
Metric
NFE
ARMP
Price
$0.69
$8.06
Analyst Decision
Buy
Strong Buy
Analyst Count
3
2
Target Price
$5.50
$15.00
AVG Volume (30 Days)
6.1M
73.3K
Earning Date
04-13-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,504,037,000.00
N/A
Revenue This Year
$110.34
N/A
Revenue Next Year
$3.54
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.56
$1.74
52 Week High
$4.96
$14.98

Technical Indicators

Market Signals
Indicator
NFE
ARMP
Relative Strength Index (RSI) 46.34 37.57
Support Level $0.59 $7.43
Resistance Level $0.77 $12.11
Average True Range (ATR) 0.07 1.12
MACD 0.01 -0.22
Stochastic Oscillator 25.87 14.20

Price Performance

Historical Comparison
NFE
ARMP

About NFE New Fortress Energy Inc.

New Fortress Energy Inc is an integrated gas-to-power company. Its business model spans the entire production and delivery chain from natural gas procurement and liquefaction to logistics, shipping, terminals, and conversion or development of a natural gas-fired generation. It has invested in floating, liquefied natural gas vessels to lower the cost of acquiring gas while securing a long-term supply for its terminals. Its segments include Terminals & Infrastructure, and Ships. It generates the majority of its revenue from the Terminals & Infrastructure segment.

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.

Share on Social Networks: